Device type · NJL
Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
NJL
Orthopedic
Device class
Class III
FDA decisions since 2015
0
510(k), De Novo and PMA
Adverse event reports
926
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Prosthesis, Knee, Patellofemorotibial, Semi-Constrained, Metal/Polymer, Mobile Bearing
- Product code
- NJL
- Device class
- Class III
- Review panel
- Orthopedic
- Specialty
- Orthopedic Surgery, Joint Reconstruction
- FDA record
- Classification database entry for NJL
Latest FDA decisions
No 510(k), De Novo or PMA decisions for this product code since 2015.
Reports received
926
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
15
1.6% of reports
Injury reports
911
98% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 2 | 91 | 0 | 0 |
| Jan 24 | 5 | 91 | 0 | 1 |
| Feb 24 | 2 | 115 | 0 | 0 |
| Mar 24 | 2 | 131 | 0 | 0 |
| Apr 24 | 0 | 125 | 0 | 0 |
| May 24 | 4 | 95 | 0 | 0 |
| Jun 24 | 3 | 79 | 0 | 0 |
| Jul 24 | 2 | 96 | 0 | 0 |
| Aug 24 | 4 | 87 | 0 | 0 |
| Sep 24 | 0 | 95 | 0 | 0 |
| Oct 24 | 0 | 124 | 0 | 0 |
| Nov 24 | 5 | 72 | 0 | 0 |
| Dec 24 | 5 | 93 | 0 | 0 |
| Jan 25 | 0 | 96 | 0 | 0 |
| Feb 25 | 0 | 78 | 0 | 0 |
| Mar 25 | 1 | 69 | 0 | 0 |
| Apr 25 | 2 | 109 | 0 | 0 |
| May 25 | 1 | 101 | 0 | 0 |
| Jun 25 | 1 | 74 | 0 | 0 |
| Jul 25 | 1 | 113 | 0 | 0 |
| Aug 25 | 0 | 84 | 0 | 0 |
| Sep 25 | 3 | 92 | 0 | 0 |
| Oct 25 | 0 | 86 | 0 | 0 |
| Nov 25 | 1 | 97 | 0 | 0 |
| Dec 25 | 1 | 92 | 0 | 0 |
| Jan 26 | 2 | 84 | 0 | 0 |
| Feb 26 | 2 | 70 | 0 | 0 |
| Mar 26 | 0 | 62 | 0 | 0 |
| Apr 26 | 0 | 62 | 0 | 0 |
| May 26 | 0 | 52 | 0 | 0 |
| Jun 26 | 1 | 74 | 0 | 0 |
| Jul 26 | 1 | 66 | 0 | 0 |
| Aug 26 | 0 | 81 | 0 | 0 |
| Sep 26 | 3 | 82 | 0 | 0 |
| Oct 26 | 4 | 89 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem707
- Loss of or Failure to Bond84
- Naturally Worn45
- Osseointegration Problem24
- Device Dislodged or Dislocated15
- Migration14
- Fracture13
- Unintended Movement13
- No Apparent Adverse Event12
- Noise, Audible6
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Unspecified Infection331
- Pain192
- Joint Laxity186
- Insufficient Information133
- Adhesion(s)28
- Loss of Range of Motion28
- Muscular Rigidity27
- Inadequate Osseointegration26
- No Clinical Signs, Symptoms or Conditions26
- Fall25
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-2394-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change
Z-2395-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change
Z-2396-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change
Z-2397-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change
Z-2398-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change
Z-2399-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change
Z-2400-2021 · Started Aug 10, 2021
Reason given: Software: A coding error associated with the Fast3D Segmentation software. During the scanning process the three images required of the hip, knee and ankle may not be aligned, causing the anatomic landmark locations to potentially result in limb malalignment.
Cause as FDA categorized it: Software Design Change
Z-1315-2021 · Started Feb 22, 2021
Reason given: Globally the company is removing 37 lots affected lots for MBT & ATTUNE (S+) Tibial Bases due to potential damaged packaging. These implant components are utilized in Total Knee Arthroplasty. The affected tibial bases are designed to be used in cemented applications.
Cause as FDA categorized it: Packaging change control
Showing the 8 newest of 269 recall records in FDA's data.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.